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Abstract 
Neurite degeneration is a cellular dysfunction commonly associated with 
neurodegenerative pathologies such as Alzheimer’s disease and Parkinson’s disease (PD). 
One common method of scoring neurite degeneration in micrographs involves calculation 
of a degeneration index (DI) using neurite fragment measurements obtained via the 
particle analyzer plugin of FIJI software. However, this method can be time consuming 
and subject to inaccuracies related to inadequate contrast. Here we describe a modified 
method for performing DI measurements with enhanced efficiency, accessibility, and 
accuracy compared to existing techniques. We developed a macro to automate the 
analysis process, enabling rapid and objective measurements of multiple images. We 
have also increased the accuracy of measurements by modifying selection criteria for 
neurite fragments, as well as by determining optimal procedures for contrast 
enhancement and removal of non-neurite materials from images. Moreover, we 
demonstrate how this method may be applied to measure neurite degeneration in an in 
vitro model of PD. To model neurite degeneration associated with PD, we treated Lund 
Human Mesencephalic (LUHMES) cells with 4-hydroxynonenal or 6-hydroxydopamine, 
compounds that induce oxidative stress. We describe culture methods, cell densities, and 
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drug concentrations that yield consistent and accurate measurements of neurite 
degeneration, and we demonstrate use of our optimized method in an experiment 
assessing the effects of c-Jun N-terminal Kinase (JNK) on neurite degeneration. Since 
neurite degeneration is a key, early-stage event associated with PD, this optimized and 
automated method may be used to gain novel insights into molecular interactions 
underlying PD progression.  
  
Keywords and phrases: neurite degeneration, neurite, Parkinson’s Disease, 
fragmentation, neurodegeneration, degeneration index, D.I., quantification, FIJI, particles 
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Introduction 
 Neurodegeneration 
 
Neurodegenerative disorders are becoming a more common issue as lifespan has 
become extended. Currently, these diseases are incurable. However, there has been an 
increased interest in understanding these disorders so that more novel therapies may be 
developed (Heemels, 2016). Some examples of these type of illnesses are Alzheimer’s 
disease (AD), Parkinson’s Disease (PD), Huntington's disease, amyotrophic lateral 
sclerosis (ALS), Multiple sclerosis (MS), and dementia. The pathophysiologies of these  
disorders are specific. However, in each case there is the progressive degeneration of 
neurons. Depending on the circumstance, this type of degeneration may result in 
cognitive impairment, issues relating to memory, and deficits in motor function. (Gitler et 
al. 2017). 
Neurons are the cells of the nervous system and they are responsible for receiving 
sensory input from the external environment and are also responsible for sending motor 
impulses to the muscles of the body, allowing for movement and everyday functioning. 
The neuron is composed of three main parts: the soma (cell body), dendrites, and axon. 
The cell body of the neuron is the spherical center of the cell that contains the nucleus 
and specialized organelles of the cell, and this area acts as a control center where 
electrical and chemical impulses are processed. Dendrites are projections from the soma 
that are responsible for receiving chemical signals from other nearby neurons. The axon 
is a single long tail-like projection off of the other side of the soma that is responsible for 
transmission of an electrical impulse known as an action potential. The axon end may 
have several branches itself so that it may innervate multiple nearby neurons or target
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cells. Axons of the central nervous system are commonly covered in what is known as a 
myelin sheath. This is a fatty white coating that surrounds the axon and acts as an 
insulator, allowing for increased speed of transmission of impulses. The myelin sheath is 
broken up into segmented parts clustering sodium channels at myelin-free interspaces—
the nodes of Ranvier—to enable saltatory action potential conduction (Ettle et al. 2016). 
Collectively the dendrites and axon of a neuron are called neurites, these specific 
structures may become degenerated/fragmented at the onset of neurodegenerative 
diseases.  
The destruction of neurites poses a problem because they are essential for 
neuronal communication and nervous system functioning. Neurons communicate using 
action potentials, which is the occurrence where there is a brief reversal of the electrical 
polarization of a neuron’s membrane. The occurrence of an action potential is what 
allows for an electrical signal to travel down and through the neuron. Normally neurons, 
when at rest, have a negatively charged internal environment due to the balance of 
potassium and sodium ion concentrations inside and outside of the cell. This 
concentration is established by the Na+/K+ -ATPase pump. This is a transmembrane 
protein that moves three sodium ions out and two potassium ions in with each pump. This 
sets up a concentration where the inside of the cell is negative compared to the outside 
environment. 
There may then be a depolarizing event initiated by a stimulus that can trigger an 
action potential through the neuron. This is an electrical signal that travels down the axon 
towards the axon terminal and synapse. During depolarization sodium gated ion channels 
open and sodium floods into the cell and this causes a local change in potential that gets 
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propagated down the axon. Once an action potential reaches the terminal the electrical 
signal induces a localized rise is calcium ion concentration within the cytosol that triggers 
the release of neurotransmitters from vesicles into the synaptic cleft. The neurotransmitter 
will then bind to receptors on the target cell leading to changes in excitability of the 
postsynaptic cell (Lodish et al. 2000). Once depolarization has occurred, there is 
repolarization and hyperpolarization of the cell, where sodium channels close and voltage 
gated potassium channels open to reestablish the resting membrane potential, until 
another stimulus triggers an action potential once again.  
The structural integrity of neurites is maintained by three different cytoskeletal 
filaments that allow for changes in cellular morphology. The filaments are microtubules, 
microfilaments, and intermediate filaments. Through interaction of these protein classes 
with each other, other proteins and different cellular membranes, the cell develops a 
defined shape and structure (Flynn 2013). Neurite fragmentation is an early stage event 
that occurs with the onset of neurodegenerative disorders, normal physiology is 
associated with healthy, intact neurites. However, with certain pathologies neurites 
become fragmented and have a negative impact on signaling between cells. As described, 
neurodegenerative diseases can have a large impact on neuron structure and cognitive and 
motor skills.  
Neurodegenerative Diseases 
 
Two of the most well-known examples of neurodegenerative diseases are 
Alzheimer’s disease (AD) and Parkinson’s disease (PD). Though there are some 
similarities among these two diseases, they are different when it comes to symptoms and 
their overall physiology. AD presents with symptoms of memory loss, confusion, issues 
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with language, poor judgment, and the inability to learn new information. Many times, 
the onset of AD is slow and subtle. There may be small lapses in memory, and this may 
be diagnosed as mild cognitive impairment (MCI). However, as the disease progresses 
symptoms can become increasingly worse and eventually may be debilitating. Typical 
duration of the disease until death is 8-10 years, and Alzheimer’s is the sixth leading 
cause of death in the United States (Rosenthal and Kamboh 2014).  
Clinical assessments of AD patients reveal the accumulation of β-amyloid plaques 
and intraneuronal neurofibrillary tangles that contain tau protein. These plaques and 
tangles interfere with calcium signaling and synaptic transmission. This brings about a 
constant state of inflammation and leads to neuronal death. Neurons in the part of the 
brain responsible for memory, the hippocampus, become damaged in AD. The entorhinal 
cortex, the area of the brain that functions as a hub in a widespread network for memory, 
navigation and the perception of time, also degenerates in AD. Neuroimaging also reveals 
that there is cerebral cortical atrophy present in AD patients (Bird 2018). With the deposit 
of β-amyloid plaques there comes neurite degeneration that may occur.  These neurites 
present as being dilated and tortuous, and often have other structural changes that affect 
organelles. For example, these dystrophic neurons may have enlarged lysosomes and 
numerous mitochondria (Selkoe 2001). There are various theories regarding why a 
patient develops AD, but one that many scientists and doctors can agree upon is that AD 
is linked to genetics. Some reports present up to a 50% genetic link to the development of 
AD. It may be difficult to directly link AD genetically because many times polymorphic 
alleles may predispose someone to AD, but not exclusively cause the onset of the disease. 
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 There are two main categories of AD, early-onset (EOAD) and late-onset 
(LOAD) so that further complicates research. Mutations in three genes, including 
amyloid precursor protein (APP), presenilin (PS)-1 and PS-2, have been linked to EOAD. 
This is promising, but the majority of AD cases are LOAD where patients develop 
symptoms when they are sixty years old or older. There has been a link between the ε4 
allele of apolipoprotein E (APOE) and the development of LOAD. APOE is a protein that 
commonly gets combined with lipids in the body to form lipoproteins that are then used 
for packaging and carriage of other fats through the bloodstream. Having the ε4 allele is a 
major genetic risk factor of LOAD, but the exact mechanism in which it influences 
development of the disease is still unknown (Rosenthal and Kamboh 2014).  
Parkinson’s Disease (PD) is the second most common neurodegenerative disease 
in the United States, affecting around 1 million people. PD symptoms include 
bradykinesia, rigidity, tremor, and postural instability. Motor incoordination is a hallmark 
of PD, but the disease also can have an effect on memory and mood (McDonald et al. 
2003). Most patients are diagnosed with PD between 55-66 years of age. With the onset 
and progression of PD there is the build-up of Lewy bodies. Lewy bodies are 
clumps/deposits of the α-synuclein protein. This can cause issues with signaling and 
motor movement (Stroud et al. 2013).   
A distinctive feature of PD is the degeneration of dopaminergic (DA) neurons in 
the substantia nigra pars compacta (SNc) brain region. Dopaminergic neurons are 
nervous system cells that produce dopamine (DA). The SNc area of the brain is 
connected to the striatum in the forebrain, which is associated with motor systems. At the 
clinical onset of PD there is only a 30% loss of total substantia nigra pars compacta 
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neurons, but there is 70-80% loss of striatal dopaminergic markers which suggests that 
axon terminals (ends of neurites) are affected earlier. With overexpression of the α-
synuclein protein there is a significant decrease in the number of motile vesicles and there 
is decelerated vesicle transport affecting transmission of neurotransmitter (Koch et al. 
2015). Studies have shown that transplantation of embryonic dopaminergic neurons have 
improved the symptoms and reinnervation of neurons in some patients with severe PD 
(Freed et al. 2001). PD may also be familial and mutations in certain genes and exposure 
to environmental toxins may lead to mitochondrial dysfunction, another hallmark of PD. 
When cells are exposed to stress linked to PD progression, there is the dual event of 
accumulation of α-synuclein protein and mitochondrial dysregulation that occurs 
(Scorziello et al. 2020).  PD also has a genetic linkage. Neuronal death has been linked to 
mutations in these PD-related genes: SNCA, LRRK2, DJ‐1, PARK2, PINK‐1 (Trist et al. 
2019). Non-genetic factors that may bring upon the onset of PD include occupational 
exposure to toxins and heavy metals (Salari and Bagheri 2018). Neurodegeneration can 
occur in many forms. Some diseases target the cell body, or the axons and dendrites 
independently. The goal of this research is to investigate neurite degeneration, in order to 
give an accurate, efficient, and more user-friendly method to quantify this type of 
degeneration.   
Neurite Degeneration 
 
Neurite degeneration can occur in a variety of ways. For example, there may be 
fragmentation or blebbing that occurs. Fragmentation involves the neurite, after exposure 
to stress, beginning to break up into smaller fragments, which poses an issue with 
impulse transmission. Blebbing refers to protrusions of the plasma membrane of a cell 
7 
 
that acts as an early cytotoxic event. This is due to reorganization of the cytoskeletal 
proteins (Lesort et al. 1997). Visually when a neuron begins to bleb, it appears as though 
the neurite begins to swell in certain areas. 
Fragmentation and blebbing are two broad categories of degeneration, but there 
are specific conditions that involve these mechanisms in the degradation process. One 
example would be Wallerian degeneration (WD). This type of deterioration relates 
specifically to axons. When an axon is injured (axotomy) it immediately separates from 
the soma and then actively executes its own destruction. After an axon has separated 
from the soma it has a lag phase where there is no change in morphology and then it will 
begin to disassemble in the way of granular fragmentation distal to the site of injury. 
Surrounding glial cells clear away axonal debris and then the process of axonal 
regeneration to reestablish connectivity occurs (Llobet and Neukomm 2019). WD is 
important for development of a neuronal network and axonal pruning. When 
degeneration occurs first at locations distal to the cell body, it occurs in a “dying-back 
fashion”. Depending on the injury and type of disease the soma may stay healthy and 
intact or it may also begin to deteriorate (Yaron and Schuldiner 2017).   
Neurite degeneration may also include loss of myelin sheath on the axon. This 
may not directly fragment the neurite itself, but it may affect the speed of transmission 
along the neurite. The cells that compose the myelin sheath are known as 
oligodendrocytes and Schwann cells. Oligodendrocytes produce myelin and wrap 
multiple axons of the central nervous system, and they also provide metabolic and trophic 
supply to help maintain neuron function (Ettle et al. 2016). Schwann cells act in the same 
way, but they are located in the peripheral nervous system and they only wrap one axon 
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at a time. With the neurodegenerative disease MS specifically, there is loss of 
myelination of the axon, presenting as a type of neurite degeneration. Depending on the 
location of the demyelination, there can be issues with walking and balance dysfunction 
(Kim et al. 2020). This type of neurite degeneration does not occur in PD since the 
neurons of the substantia nigra are not myelinated (Sulzer and Surmeier 2012). Many 
times, neuronal death and injury occurs in response to oxidative stress and interactions 
with reactive oxygen species.  
Oxidative Stress / ROS   
 
When discussing cellular dysfunction, exposure to oxidative stress and reactive 
oxygen species (ROS) plays a critical role in the onset and progression of neurological 
pathologies. Oxidative stress is cellular condition in which there is the imbalance of ROS 
and naturally occurring antioxidants. ROS are generated during aerobic metabolism, and 
these are highly chemically reactive transient species that contain oxygen that may form 
adducts with and interact with DNA, proteins, carbohydrates, and lipids in a destructive 
manner. Oxygen has a high electron affinity. ROS may include free radicals like the 
superoxide anion (O2
-), hydroxyl radicals (-OH) and the nonradical hydrogen peroxide 
(H2O2). Free radicals are uncharged molecules that have an unpaired valence electron. 
Due to this reason, they are extremely reactive and can cause damage to cells via 
oxidation. This is the process of loss of electrons. In this situation an ROS may interact 
with a macromolecule and “steal” one of its electrons, causing cellular dysfunction. Not 
all ROS are considered free radicals, but they can cause degeneration nonetheless 
(Curtain et al. 2002). Mitochondrial production of ATP, inflammation, and phagocytosis 
are endogenous processes that may produce ROS. Mitochondria produce ATP through 
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oxidative phosphorylation. Many times, the mechanisms that remove damaged 
mitochondria are altered in PD systems. This is an autophagy process that is specifically 
called mitophagy. If there is this type of alternation there may be accumulation of 
damaged mitochondria that may lead to oxidative stress and irreversible apoptotic cell 
death (Scorziello et al. 2020). Oxidative stress is present in other neurodegenerative 
disorders and this may be due to the fact that the central nervous system is a highly 
aerobic environment that requires a high energy source and mitochondrial function, so it 
is more susceptible to this particular kind of stress. The brain requires 20% of body basal 
oxygen to function (Cenini et al. 2019). Environmental sources such as exposure to x-
rays, ozone, cigarette smoking, air pollutants, and industrial chemicals may also cause 
formation of ROS and other free radicals (Lobo et al. 2010). 
Oxidative stress may induce cell death via necrosis or apoptosis. Necrosis occurs 
usually in response to severe trauma to the cell. Morphological changes present as 
cytoplasmic and mitochondrial swelling, plasma membrane rupture and release of the 
cellular contents into the extracellular space. Induction of the immune response to clean 
up cellular debris may cause even more death to neighboring cells. Apoptosis is 
programmed cell death and this function is much more tightly regulated. The cell begins 
to depolarize and fragment into what are called apoptotic bodies (Curtain et al. 2002).  
Cells within the body naturally have antioxidant defenses but as there is an 
increase of ROS and free radicals there may be an imbalance that leads to oxidative 
stress. Diet may introduce additional antioxidants to help combat this issue. Antioxidants 
work by directly scavenging ROS and providing them with a free electron. Some 
examples of antioxidants obtained from diet are β-carotene, vitamin C and vitamin E. 
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Foods that are rich in antioxidants include berries, cherries, citrus, prunes, and olives. 
Green and black teas are also a great source of antioxidants (Lobo et al. 2010).  
In relation to PD, there is evidence of increased ROS presence in the substantia 
nigra region of postmortem brains of PD patients (Cenini et al. 2019). In many cases, in 
order to research and properly model PD, investigators will use drugs that will chemically 
induce oxidative stress. One of the most popular toxins that induces neurite degeneration 
is 6-hydroxydopamine (6-OHDA). This is a synthetic organic compound that promotes 
the select degeneration of DA neurons. The chemical structure of 6-OHDA is very 
similar to the chemical structure for DA, apart from a hydroxyl group attached to the 
sixth carbon of the ring. This is important to note since it is brought into the neuron via 
dopamine reuptake transporters. 6-OHDA has been shown to disrupt complex I of the 
mitochondrial electron transport chain as well as increase production of ROS, which 
contribute to neuronal death via apoptosis. Molecules of 6-OHDA may even combine to 
form quinones, a type of ROS. In one study, use of 6-OHDA immediately saw the 
dysfunction of mitochondrial transport, and this event was blocked by use of the anti-
oxidant N-acetyl-cysteine (NAC) suggesting that free radical species played a role in this 
process (Lu et al. 2014). This type of degeneration may present as axonal blebbing and 
fragmentation. Another drug used to chemically induce PD is 1-methyl-4-phenyl-1,2,3,6-
tetrahydropyridine (MPTP). This compound also selectively kills DA neurons and has 
been linked to immune system depression (Basu and Dasgupta 2000).  
Fragmentation of neurites may also occur experimentally after exposure to 
4-hydoxynonenal (HNE). This is a byproduct of lipid peroxidation. This is the event 
where the lipid membrane of a cell is oxidized. HNE may form covalent adducts with 
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macromolecules and disrupt their function (Zhong and Yin 2014). HNE can induce 
inflammation and trigger apoptosis. HNE preferentially forms adducts with cysteine 
residues of thiol-containing proteins, a number of which are proteins involved in redox 
signaling (electron transfer reactions). Thiol groups are organic compounds that have the 
form R-SH, so they are very similar to alcohols, but there is a sulfide instead of an 
oxygen. One such protein that HNE may interact with is c-Jun N-terminal kinase (JNK) 
(Breitzig et al. 2016). This is a protein associated with stress signaling pathways. These 
pathways may be triggered with exposure to cytokines, growth factors, and oxidative 
stress. JNK is activated via phosphorylation. These signaling pathways have been shown 
to have a key effect on apoptosis signaling. In relation to AD, JNK proteins have been 
reported to increased amyloid beta production and contribute to the development of 
neurofibrillary tangles (Yarza et al. 2016). When it comes to PD, JNK protein blockage 
has also been shown as an effective way to alleviate oxidative stress brought on by other 
neurotoxic drugs (Wang et al. 2004). One way to block JNK is through the use of an 
inhibitor such as SP600125, a chemical used to block phosphorylation. The concept of 
oxidative stress is important in relation to PD because many times there is the induction 
of oxidative stress within cell cultures in order to model and research PD.  
Parkinson’s Disease  
 
Parkinson’s patients experience degeneration of dopaminergic neurons 
specifically. These neurons produce dopamine, which is a neurotransmitter and hormone 
with many important functions. It primarily is associated with motor coordination and 
motivation. DA is produced in the substantia nigra, ventral tegmental area, and 
hypothalamus of the brain. It is made from the conversion of the amino acid tyrosine into 
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levodopa (L-dopa) via the enzyme tyrosine hydroxylase (TH). Presence of this enzyme 
indicates presence of DA neurons. The L-dopa compound then undergoes an enzymatic 
process to become dopamine. This specific neurotransmitter acts as a precursor itself to 
other neurotransmitters like epinephrine and norepinephrine, so degeneration of DA may 
also have an effect on sleep, dreaming, mood, attention, working memory, and learning. 
Degeneration of DA neurons is not only limited to PD patients. On average there is a 5-
10% decrease of overall DA neurons with every decade of life as there is an increase in 
brain oxidative damage relating to aging (Olguin et al. 2015).  
DA neurons are susceptible to oxidative stress and degeneration due to their 
negative mitochondrial membrane potential. When treated with MPTP, the DA neurons 
of primates and mice saw degeneration due to MPTP’s metabolite MPP+ concentrating in 
the mitochondria. Similar to 6-OHDA, MPP+ is also uptaken into the DA transporter 
(DAT). Another theory as to why DA neurons are more vulnerable to degeneration 
relates to energy production. Axons of the SNc are not myelinated which may mean they 
have a decreased abundance of substrates to support ATP production. This can pose an 
issue because if DA neurons are intrinsically more energetically challenged then they 
might be predisposed to mitochondrial insults (Haddad and Nakamura 2015). Other 
factors like calcium, iron dysregulation and antioxidant deficiencies may also affect the 
neuronal redox balance which may make DA neurons more susceptible to degeneration 
as a person ages.  
In individuals with PD, the DA neurons of the substantia nigra brain region 
become degenerated. This area of the brain is located in the mesencephalon (midbrain). 
This brain region is a basal ganglion structure, meaning it is linked to the thalamus at the 
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base of the brain and it is involved in coordination of movement and reward. The term 
substantia nigra means “dark substance” due to the high neuromelanin content which 
forms from the L-dopa precursor in dopamine synthesis (Sonne et al. 2020). This section 
is made up of two subsections called the substantia nigra pars compacta (SNc) and the 
substantia nigra reticulata (SNr). The two sections lie medially to each other. The neurons 
of the SNc are very densely packed and reach the striatum (a structure in the forebrain) 
and supply it with dopamine. The striatum is associated with fine motor movements and 
action planning. The neurons of the SNr project out and are considered to be GABAergic, 
meaning they release Gamma aminobutyric acid (GABA), an inhibitory neurotransmitter, 
so it blocks impulses between nerve cells. The SNr as a whole contributes to seizure 
suppression (Zhou and Lee 2011). Neurons of the SNc often begin to degenerate first at 
the ends of the neurites and then progress in a dying back fashion (Grosch et al. 2016). 
Once PD presents symptoms clinically there is already substantial loss of DA neurons 
between the SNc and the striatum. 
There are three major dopamine pathways that Parkinson’s is related to, the 
mesolimbic, mesocortical and nigrostriatal pathways. The mesolimbic pathway is often 
referred to as the reward pathway as it mediates pleasure signaling. It connects the ventral 
tegmental area (VTA) in the midbrain to the ventral striatum of the basal ganglia in 
the forebrain. This is a connection that goes to parts of the limbic system, which is a set 
of structures associated with motivation, emotion, learning, and memory. The VTA 
specifically is a group of neurons near the midline of the brain that acts as the origin of 
DA cell bodies for these pathways. The mesocortical pathway runs from the VTA to the 
cerebral cortex- the thin layer of the brain that covers the cerebrum. The cerebrum is the 
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largest part of the brain that spans from the frontal bone to the occipital bone. The 
cerebral cortices’ main functions are associated with attention, perception, awareness, 
thought, memory, language, and consciousness. The purpose of this pathway is to 
regulate cognitive control, motivation, and emotional response (Luo and Huange 2016). 
Pathologies of this pathway may include schizophrenia. This type of disorder results from 
an excess of DA. The final pathway is known as the nigrostriatal pathway. This pathway 
connects the SNc with the dorsal striatum in the forebrain. Neurons in the SNc synapse 
on and release DA onto GABAergic neurons of the striatum. With the combined presence 
of DA and GABA neurotransmitter there is the induction of voluntary fine motor control 
within basal ganglia circuitry/motor loops (Bourdy et al. 2014). DA neurons of the 
nigrostriatal pathway have a higher basal rate of mitochondrial oxidative phosphorylation 
and ATP production and a smaller reserve capacity compared to less vulnerable DA 
neurons of the VTA, relating to the mesocortical and mesolimbic pathways. Neurons in 
the nigrostriatal pathway seem to also be more vulnerable due to complex axonal 
arborization; this is the process of development of tree-like branching that occurs 
(Giguere et al. 2019).  
Dopamine interacts with many parts of the brain, but it is not the only 
neurotransmitter affected by PD. Patients with PD may also present with secondary 
mood-related symptoms in addition to motor impairment. Many times, PD patients also 
have issues with depression and anxiety related to the neurotransmitter serotonin. The 
area of the brain known as the raphe nuclei (RN), located in the brainstem, is responsible 
for production and release of serotonin and with early stages of PD there is Lewy body 
pathology that presents in this area. There is a reported loss of 56% of serotonergic 
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neurons in the median RN area of PD patients. This loss was correlated with depression 
in PD patients (Grosch et al. 2016). This relates to data from actual PD patients, but when 
studying neurodegeneration that presents in PD in a research setting, most data comes 
from animal models. There is a multitude of previous literature and research that can be 
drawn upon, but each source may vary in techniques and experiments used.  
Studying PD in a Research Setting  
 
Parkinson’s disease may be modeled in a research setting using cell culture lines 
of DA neurons or it can also be modeled by working with tissue samples taken from test 
rodents. This relates to the difference between primary and secondary cell culture. 
Primary cell culture involves dissection and dissociation of cells from animal or plant 
tissue directly through mechanical or enzymatic processes and then maintaining growth 
of those cells in a suitable outside environment. These cells may easily be contaminated 
with mycoplasma (a type of bacteria) so in many cases they may be treated with 
antibiotics (Geraghty et al. 2014). Secondary cell culture involves taking cells from the 
primary culture and putting them into a new vessel with fresh growth media. This enables 
longer lifespans of the cells and the opportunity for expanding cell populations. One thing 
to note is that secondary culture may invariably cause genetic changes from the original 
primary culture. In our experiments we use secondary cell culture.  
In research settings PD may be modeled chemically by use of certain drugs that 
induce oxidative stress, or it may be modeled genetically. This is where an investigator 
might bring about the onset of PD by disrupting genes associated with the disease. Most 
commonly PD is modeled chemically by use of 6-OHDA injected intracranially 
(Taherianfard et al. 2020). Other investigators may choose to manipulate genes 
16 
 
associated with PD to induce the same type of Parkinsonism symptoms. These specific 
genes may be targeted for mutation to generate “knockout” mice/rats. Most commonly 
there are three genes, PINK1, Parkin and DJ-1, that if manipulated to induce loss-of-
function will result in recessively inherited PD onset. Gain-of-function single point 
mutations in the LRRK2 and α-synuclein genes have been linked to dominantly inherited 
PD. When inducing PD genetically in animal models, it has been suggested that rats may 
be a better option than mice to investigate. This is because mice that are genetically 
manipulated show no greater than 50% nigral DA neurons. However, rat genetic models 
routinely produce greater than 50% nigral DA neuronal cell loss, most similar to human 
onset of PD (Creed and Goldberg 2019).  Though it is obvious that PD has been heavily 
researched, there are some techniques that specifically are used when investigating 
neurite degeneration.  
 In a broader sense, PD can be modeled using cell culture, which is a type of in 
vitro representation, or it may be modeled in vivo. The difference is where 
experimentation is occurring. In vivo studies investigate cells in their native conditions 
and in vitro studies have removed the cell from its natural environment and it is placed in 
an artificial environment that mimics natural biological conditions. For in vivo studies of 
PD, rodents such as mice and rats are commonly used to model human patients. One 
common approach involves the stereotaxic injection of oxidative stress inducing drugs 
(like 6-OHDA) into the medial forebrain of the animal. The word stereotaxic refers to a 
three-dimensional surgical technique that allows for areas deep within tissue to be treated 
chemically. With the intracranial injection of 6-OHDA there may be death of up to 60% 
of tyrosine-hydroxylase containing neurons (Salari and Bagheri 2018).   
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Our research makes use of experimentation with cells from the Lund human 
mesencephalic (LUHMES) cell line. These cells are derived from 8-week-old human 
mesencephalon embryonic tissue. In order to immortalize the cells, DNA from a cancer 
gene called v-myc was introduced to encourage rapid division. This gene is near a 
tetracycline-controlled promoter, so inactivation of the v-myc gene may occur if the cells 
are treated with tetracycline, a type of antibiotic. Once these cells have been treated with 
tetracycline they develop into post-mitotic neurons and develop a neuronal network as 
their neurites begin to flourish morphologically. This process is called differentiation. In 
addition to tetracycline, differentiation media also includes glial cell-derived neurotrophic 
factor (GDNF) and dibutyryl-cyclic AMP (db-cAMP). GDNF is a protein that promotes 
survival of neurons and db-cAMP signaling pathway activation is required for GDNF to 
have positive impact on the neurons. In one study combined treatment of mesencephalic 
cultures with db-cAMP and GDNF accelerated the onset of the survival effects of GDNF 
on dopaminergic neurons, resulting in a 1.5-fold increase in the number of surviving TH 
neurons at 3 days in vitro (Engele and Franke 1996). These cells are used in modeling PD 
because they express dopaminergic neuron specific markers. These cells may be treated 
with stress inducing drugs and then different aspects of their degeneration may be 
measured. Analysis of protein before and after treatment may occur via western blot 
analysis or by use of immunostaining. Neurite degeneration may be visualized using 
microscopy to see axonal blebbing or fragmentation (Zhang et al. 2014). 
Previous Research of PD 
 
 Degeneration of a neuron may present in many different ways. For example, 
there can be degeneration of the soma, loss of myelination, blebbing or fragmentation of 
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neurites. In our research we want to evaluate deterioration of the neurites in a fragmented 
manner. Several methods for measuring neurite degeneration have been previously 
reported. These methods may be put into two categories: automated and manual methods. 
Both may make use of imaging software, for example, ImageJ or the new modified 
version of this program, FIJI.  
One team of investigators chose to investigate how human nerves in the 
peripheral nervous system (PNS) degenerated via counting axon tracts with manual, 
semi-automated and automatic methods. They did so by taking nerve biopsies of patients 
with facial palsy. This is a condition that also goes by the name of Bell’s palsy, and it is 
characterized by the paralysis of facial muscles on one side of the face, due to 
dysfunction of the facial cranial nerve. In this study grayscale micrographs of the nerve 
fascicules (bundle of axons in the PNS) were acquired and processed using FIJI software. 
This team made use of tools in FIJI to trace and cut the cross-section image of the 
sample, and manual counts of the axons were performed by an independent blinded 
examiner. This method examined the axon count as a way to measure degeneration 
present in facial palsy patients.  This was in contrast to their semi-automatic counts where 
they used a function of FIJI to analyze and detect particles of a certain size to count the 
axons automatically. This version of the method was not fully automated because 
additional steps were done manually in order to increase the contrast of the starting 
images. These steps included increasing the contrast and then binarizing the image. 
Binarization of the image means to convert it into black and white so that the neuron 
structure is black upon a white background. This concept is related to “thresholding” an 
image, where pixels are divided into two or more classes. In this situation the two classes 
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are the “background” and “foreground” of the image. The team fully automated the 
method by use of a macro in FIJI. Macros are lines of script within the software that 
allow for simultaneous application of separate and numerous modifications to whole 
image sets. The time difference between manual and automated methods was astounding, 
as the manual method for 129 biopsies took 21 hours and 6 minutes, when in comparison 
the semi-automated method only took 1 hour and 47 minutes (Engelmann et al. 2020).  
Other studies investigate length of neurite outgrowth as a way to quantify 
degeneration. One example relates to the work of a team of experimenters that 
demonstrated the quantification of axonal degeneration present in dorsal root ganglia 
(DRG) due to the withdrawal of the neurotrophin Nerve Growth Factor (NGF). The DRG 
is a ganglion (a group of neurons within the PNS) that is located within the dorsal root of 
the spinal nerve. In their experiments they introduced a way to measure axonal density 
over an entire field of radial outgrowth from the ganglion. In vivo DRG axons connect 
other peripheral tissues to spinal tissue. DRG also respond positively to NGF, which 
binds to receptors on growing DRG axons and initiates a pro-growth and pro-survival 
signaling cascades. Neurons that reach their target flourish, but those that do not 
degenerate (Johnstone et al. 2018). Instead of using an in vivo model, the researchers 
used explant DRG–transferred from animals to a nutrient media– and measured axonal 
degeneration from micrographs using Axoquant 2.0 in R studio. This program (Axoquant 
2.0) was created by the authors and is an R script (text file in the programming language 
R). This program gets opened in R Studio. R Studio is a graphical interface for editing 
and running R packages. This tool avoids variations in random sampling of neurons by 
instead reporting the degree of degeneration over the entire radial growth field from the 
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soma to the growth cone. A growth cone is a large actin supported extension of a growing 
neurite seeking its synaptic target. Results are reported as distance from the soma x area 
occupied by the axons. One strength of this experiment is that it is not prone to any type 
of bias since it is not relying on random sampling, and it is not dependent on the 
researcher’s decision of whether an axon is degenerated or not, and there are no 
variations of what type of fragments are excluded from degenerative data. Another 
advantage is that the researchers used an automated microscope stage to get pictures in 
consistent areas across the DRG sample, along with the assurance of carefulness and 
consistency when it comes to handling the cells. The authors suggest that this program 
may work for other models of neurodegeneration as well– such as those brought on by 
oxidative stress (Johnstone et al. 2018).  
Another example of a team investigating changes of total neurite outgrowth 
length in relation to neurite degeneration is the work of a research group that made use of 
stereology to examine degeneration. The experimenters began by performing an 
intercranial injection of 6-OHDA into the nigrostriatal pathway of a rat brain. In order to 
count axonal projections in a 3D sample (tissue), the Spaceballs stereological probe was 
utilized. This instrument estimated length in a 3D region for normal and dystrophic 
axons. Dystrophic axons may be fragmented, twisted or present with blebbing. This tool 
worked by creating a 3D hemi-sphere embedded within the tissue slice being examined. 
Each projection that intersected the exterior bounds of the sphere was counted to create 
an estimate of the total length per region examined. The results showed that the treated 
brain areas showed a dying back pattern of neurodegeneration in response to 6-OHDA, 
even areas of the brain not directly related to the injection site showed degeneration since 
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the axons are the first things to become damaged. The researchers also noted that 
dystrophic axons generally had larger diameters than healthy ones. This was an example 
that related to an in vivo study to give more information on types of methods used to 
quantify neurite degeneration. Our research is an in vitro model that makes use of a 
degeneration index. 
 Prior research also indicates that measuring a degeneration index (D.I.) may be 
helpful when quantifying neurite degeneration. This is the process where total neurite 
area of a binarized microscopic image is measured in pixels in the FIJI software and then 
that number acts as the denominator in an equation. The numerator of the equation is the 
total pixel area occupied by fragmented neurites. To measure neurite area the particle 
analyzer function in FIJI is used to detect particles/fragments of a certain pixel size and 
circularity. Prior to any measurement of neurite area, the cell bodies present in the 
micrograph are manually selected and removed via use of the eraser tool in FIJI. The D.I. 
is calculated as the ratio of fragmented neurite area over total neurite area. This gives a 
representative number to symbolize the degree of fragmentation a particular treatment 
condition may have on neurites (Sasaki et al. 2009).  Since this is a ratio, a numerically 
smaller number represents a healthy culture, and a larger number represents a 
degenerated culture. This is a common method for quantifying neurite degeneration via 
performance of a D.I. calculation. While this method has been used by different research 
groups, it is normally a manual method that may be prone to user error and investigator 
bias (Sasaki et al. 2009). To help alleviate some error that occurs with these techniques, 
we have optimized the method to increase its accuracy, efficiency, and user-friendliness.  
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Our Research 
 
 Our experiments have tested the implementation of several modifications 
designed to increase efficiency, accuracy, and accessibility, when compared to traditional 
methods for performing degeneration index calculations. These adjustments include using 
the background correction function of the microscope during the image capture process. 
Once the images have been obtained and are brought into the FIJI software, brightness 
and contrast of the image may be adjusted and enhanced in order for more accurate 
representation of neurites. FIJI is unique in that investigators may create their own 
programs to accomplish tasks not originally programmed within the software. These 
programs may be uploaded and used, and they are referred to as plugins. One such plugin 
removes particles of certain size and circularity that investigators may want to exclude 
from their data. When it comes to measuring the fragmented neurites, the pixel particle 
size detection range makes a difference in the output D.I. results. We also have modified 
selection criteria for fragmented neurites. Another change we implemented is use of 
fluorescent micrograph images as opposed to phase contrast images. Our research makes 
use of immunostaining for the β-III tubulin protein to obtain fluorescent signal to be 
visualized via fluorescent microscopy. This is a protein also referred to as TUJ-1 that 
comprises the microtubule network of the cytoskeleton. Microtubules are hollow tubes 
that play a role in processes like mitosis and motility, and they are made up of two 
subunits: alpha and beta tubulins. Depending on a cell’s need, microtubules can rapidly 
grow/shrink via polymerization processes. Specifically, β-III tubulin is found in neurons 
and it has functions in neurogenesis and axonal maintenance (Jouhilahti et al. 2008). The 
largest and most helpful enhancement tested involves the automation of the entire process 
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to quickly and efficiently obtain accurate D.I. scores so that neurite degeneration may be 
quantified. For this process to work, there was also immunostaining using 4’,6’-
diamidino-2-phenylindole (DAPI). This is a fluorescent stain that selectively binds to the 
adenine-thymine-rich regions of DNA allowing for visualization of the nuclei. In our 
automated method binarized DAPI images are subtracted from binarized neurite images 
to automate the process of cell body removal. Since neurite degeneration is a key, early-
stage event associated with PD, this optimized and automated method may be used to 
gain novel insights into molecular interactions underlying PD progression. 
Experimental Procedures  
Coating Slides 
 
Eight well chamber slides from the brand SPL Life Sciences were used in our 
experiments. The slides were initially coated with 200 µg/mL poly-L-ornithine (Sigma) 
for at least twenty-four hours and then were washed with sterile water. The slides were 
then coated with 2 µg/mL fibronectin (Sigma) for three hours while incubated at 37℃. 
After incubation, the slides were once more washed with sterile water and then were 
covered with 100 ng/mL poly-D-lysine (Sigma), and 10 µg/mL laminin (Corning, 
Corning, NY) for another twenty-four-hour period. Once this time had elapsed, the slides 
were washed for one final time and were left out to air-dry and then were stored at 4℃ 
until further use.  
Cell Culture 
 
To emulate the dopaminergic cells that are destroyed in Parkinson’s Disease, in 
our experiments we used Lund human mesencephalic (LUHMES) cells. The cells were 
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plated at a cell density of 85,000 cells/well to ensure enough separation between neurite 
tracts yet still consisting of a healthy culture. Cells were incubated in growth medium 
consisting of DMEM/F12 (Gibco, Waltham, MA) supplemented with 2 mM glutamine 
(VWR, Radnor, PA), 1% (v/v) N-2 supplement (Gibco), and 40 ng/mL basic fibroblast 
growth factor (R&D Systems, Minneapolis, MN). Once the cells had proliferated enough 
times and were of a confluency fit for treatment, they were differentiated into post-
mitotic neurons by replacing their growth media with a media which also included 1 
µg/mL tetracycline (Sigma), 1 mM N6,2′-O-Dibutyryladenosine 3′,5′-cyclic 
monophosphate (db-cAMP) (Enzo Life Sciences, Farmingdale, NY), and 2 ng/mL glial 
cell line-derived neurotrophic factor (GDNF)(R&D Systems). These components were 
added into a media that included DMEM/F12 + N2 supplement. The basic fibroblast 
growth factor was not included in this mixture, as to not promote further cell division. 
Cells received a half-volume media change every other day prior to treatment.  
Cell Treatments and Fixation 
 
Once cells reached their fifth day of differentiation, they were either treated with 
varying concentrations of 6-hydroxydopamine (6-OHDA) (Sigma), 4-hydroxynonenal 
(HNE) (Cayman Chemical, Ann Arbor, MI), or vehicle solution. 6-OHDA was prepared 
in cold phosphate-buffered saline (PBS) containing 0.02% ascorbic acid, and HNE was 
dissolved in chilled absolute ethanol. All aliquots of 6-OHDA and HNE were stored at -
80o C under inert gas and protected from light. To assess the effects of c-Jun N-terminal 
Kinase (JNK) on neurite degeneration some experiments involved pretreatment with the 
JNK inhibitor SP600125 (Sigma-Aldrich). This was to show that our technique worked 
with changing variables. All inhibitors were prepared in DMSO and stored under inert 
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gas in frozen aliquots that were protected from light. The cells were treated for twenty-
four hours and then were fixed. The fixation process involves exposing the treated cells 
to 4% paraformaldehyde (PFA) for a twenty-five-minute period and then they were 
placed in sterile PBS.  
Immunostaining 
 
 Once cells were fixed, they were immunostained to visualize ßIII-tubulin protein 
and the nucleus of the cells. After fixation, the cells were permeabilized using 0.1% 
Triton™ X-100 (Sigma-Aldrich) in PBS. The cells were then blocked for one hour in 
PBS containing 10% normal goat serum and 0.1% Triton™ X-100. The cells were then 
incubated at 4℃ overnight while exposed to the primary antibody for ßIII-tubulin 
(Covance, Princeton, NJ; 1:1000). The following day the cells were washed twice using 
and 0.1% Triton™ X-100 and twice with sterile PBS and then were placed in secondary 
antibodies coupled to the Alexa Fluor 488 (Thermo Fisher Scientific; 1:1000) 
fluorophore. After 90 minutes at room temperature elapsed, the cells were then washed 
again twice using and 0.1% Triton™ X-100 and twice with sterile PBS and then 5 µg/mL 
4’,6’-diamidino-2-phenylindole (DAPI) in PBS was applied for 5 minutes at room 
temperature. After the cells were incubated in DAPI the cells received a final wash, twice 
using and 0.1% Triton™ X-100 and twice with sterile PBS and the slides were cover 
slipped using Fluoromount-G® mounting medium (Southern Biotech, Birmingham, AL). 
All slides rested in a dark and dry place for at least 24 hours before any type of 
microscopy imaging took place.  
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Image Capture 
 
  For capturing images of the treated cells, the NIS Elements Acquisition software 
was used in conjunction with a Nikon inverted microscope. Kohler illumination was 
performed prior to each image capture session. Cells were visualized using both phase 
contrast (PC) and fluorescent microscopy. For phase contrast microscopy images were 
captured at a 20x magnification and with a gain of 1.00x and a 21 second exposure time. 
The plain filter turret was used for PC images. For all images, the correction collar on the 
objective was set to 0.17 and the light intensity dial was set to the beginning of the 
seventh highest light intensity notch. Prior to image capture of the cells there was a 
background image taken and background correction was applied within the software for 
each PC image captured. For each well of the slide there were five representative images 
taken. Preferred areas to image were areas where the neurite tracts were clearly defined, 
and cells were not too confluent or sparse. The images were saved as TIFF and ND2 files. 
While keeping the location frame the exact same for each image, fluorescent images were 
also taken. For these images specifically the green filter turret was used to view the TUJI 
staining and the exposure time was 1 second. The background correction function was 
not used for fluorescent images. The spinning disk filter was adjusted to shine the blue 
LED light onto the sample of cells. Normal exposure times for fluorescent images ranged 
from 900 ms-2 s. The gain was set at 1.20x. After the fluorescent images were captured 
the LED light source was removed from the sample to prevent photo-bleaching the cells.   
Once PC and fluorescent images to visualize β-III tubulin were taken for each 
representative area within the well, DAPI images were also taken for those same areas. 
To do this the blue filter turret was used and the exposure time was 125 milliseconds with 
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a gain of 2.80x. The background correction function was not used for DAPI images, and 
the ultraviolet disk was used. The same care was taken to avoid photo-bleaching for 
DAPI images. Once the PC, fluorescent, and DAPI images were taken for each area of 
the well they were saved as both TIFF and ND2 files and were then ready to be processed 
and quantified. Then these files were sorted into PC, fluorescent, and DAPI folders on the 
computer for organizational purposes. 
Traditional DI calculation 
 
 FIJI software was used to analyze the images. Traditional DI calculations were 
performed by opening the images as TIFF files with FIJI and then all five images from 
each area of a well were viewed and manipulated at the same time by putting the images 
into a stack. For PC images the background was set to white and the foreground color 
was set to black. The images were then binarized and the cell bodies were removed using 
a tablet, stylus, and the eraser tool function in FIJI. Particle analyzer function was used. 
To measure total neurite area the measure setting was used, and the number was 
recorded. To measure neurite fragments the analyze function was used measuring size 
from 20-10,000-pixels and the circularity settings were 0.20-1.00. This number was 
recorded and then neurite fragment area was divided by the total neurite area to obtain a 
D.I. This process was repeated for each treatment condition well.  
Optimized DI calculation 
 
 The traditional method had issues, and so within our research we made use of an 
optimized method to quantify neurite degeneration. After traditional image capture and 
putting the TIFF files into FIJI the images then had their contrast and brightness levels 
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adjusted such that the lookup table ranged from 90-205. The images were then binarized 
and the cell bodies were removed using a tablet, stylus, and the eraser tool function in 
FIJI. Once the cell bodies were removed from the images, the particle remover plugin 
was used to remove small, non-neurite debris and artifacts from the image. This was used 
with the settings of a size of 0-9.0 pixels and a circularity of 0.20-1.00 to remove these 
specific particles. Once the particles were removed to a white background, then the 
measure and particle analyzer functions were used. To measure total neurite area the 
measure setting was used, and the number was recorded. To measure neurite fragments 
the analyze function was used measuring size from 10-10,000-pixels and the circularity 
settings were 0.20-1.00. This number was recorded and then neurite fragment area was 
divided by the total neurite area to obtain a DI. This process was repeated for each 
treatment condition well. 
Macro Development  
 
 An important feature of the automation process was the development of a macro 
to incorporate all the modifications for enhancement. Depending on if the starting image 
is a PC or fluorescent image the macro maybe different. One additional folder was made 
on the computer for each well to organize output images. For PC images the major steps 
performed by macro are as follows: open neurite image> convert to an 8-bit image> 
adjust brightness and contrast so that the grayscale range is 90-205> adjust the colors so 
that the foreground is black and the background is white> binarize image> use of particle 
remover plugin to remove particles with a size between 0-9.0 pixels and a circularity of 
0.00-1.00 pixels> open DAPI image> convert to an 8-bit image> adjust brightness and 
contrast so that the grayscale range is 0-195> binarize image> use of particle remover 
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plugin with a size setting of 0-9.0 pixels and a circularity of 0.00-1.00 pixels> dilate ten 
times> erode four times> subtraction of DAPI image from the neurite image> take 
measurement of new area of image> particle analysis using a 10-10,000-pixel size and a 
0.20-1.00 circularity>save results. The results for total neurite area and fragmented 
particle area are saved and exported to an excel file for viewing and calculation of the 
D.I.  
Fluorescent images were processed in a similar fashion, with the exception that 
when the brightness and contrast was adjusted initially for the neurite image, the lookup 
table range was from 0-195. After the automated method was applied, D.I. values were 
calculated for each well’s treatment condition.  
Results and Figures 
 In the present research we found a way to better enhance accuracy and efficiency 
of the quantification of neurite degeneration. From qualitative data, we observed 
differences between the traditional and enhanced method. The following figure depicts a 
schematic of the traditional method used to calculate a D.I. Within this process image 
capture using PC microscopy occurs as shown in panel 1A. Images are then opened in 
FIJI and then binarized, as shown in panel 1B. Panel 1C presents the result of manual cell 
body removal. Total neurite area is measured and then particles with a pixel size of 20-
10,000-pixels are detected in panel 1D and then a D.I. is calculated in panel 1E. 
30 
 
 
 
Figure 1. Traditional method for quantifying neurite degeneration with a 
degeneration index (D.I.). A; a phase contrast image of the treated LUHMES cells B; 
binarized version of the  
phase-contrast image once the image has been put into FIJI software C; soma/cell body 
removal via use of the eraser or freehand selection tool in FIJI D; particle detection of 
fragments that have a size of 20-10,000-pixels and a circularity of 0.20-1.00 E; 
Calculation of the degeneration index (D.I.) that represents the ratio of fragmented 
neurite area over total neurite area. The scale bar indicates 100 µm.  
Additional steps in the image acquisition process were added so that issues with 
background shading once an image was binarized could be alleviated. The image set in 
Figure 2. shows the qualitative data for using background correction settings within the 
Nikon microscope acquisition program. In this figure we see visually a phase contrast 
image in panel 2A that was captured without background correction being applied. Once 
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binarized, shown in 2B, the image presents with a lot of background shading that will 
influence the total neurite area. This is in contrast to the PC image that does have 
background correction applied in 2C. Once this image has been binarized, shown in 2D, 
it appears to more accurately depict the neurites without any shading that will affect the 
D.I. calculation.  
 
Figure 2. Use of the background correction function during image acquisition. A; 
indicates an original phase contrast (PC) image that was captured without background 
correction B; the binarized version of the PC that presents with background shading C; 
indicates an original PC image that was captured with background correction D; the 
binarized version of the PC image that had background correction applied. The scale bar 
indicates 100 µm. 
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 Once images were opened in the FIJI software there were additional 
modifications made that related to contrast and brightness. The effect of these 
adjustments are shown in Figure 3. These levels were adjusted so that neuron structure 
better stood out from the background. Poor contrast was an issue that detrimentally 
affected the accuracy of binarized PC images; once the images with poor contrast were 
binarized (3A and 3C), healthy neurites presented as being fragmented in a sort of 
artificial fragmentation. Once the brightness and contrast levels were optimized for a PC 
image, the binarized version had a reduction in artificial fragmentation (3B and 3D).  
 
Figure 3. Brightness and contrast adjusted images. A; indicates and original phase 
contrast image, as shown, the neurite highlighted within the red oval has low contrast B; 
the manipulated PC image that has brightness and contrast enhancements applied in FIJI, 
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making the neurite more noticable C; the binarized version of the original PC image that 
presents with artificial fragmentation of the neurite D; the binarized version of the 
manipulated PC image that more accurately resembles the healthy neurite from images A 
and B. The scale bar indicates 100 µm. 
 When it comes to measuring area of the neurites, another function we 
implemented for establishing our enhanced method made use of the particle remover 
plugin in FIJI. This plugin visually and qualitatively removes a lot of the background 
shading that may occur in an image once it is binarized. Such artifacts can result from 
cellular debris or dust, or from not using background correction during image acquisition. 
In this image set shown in Figure 4 we can see the difference between using the plugin 
set to remove particles that are between 0-9.0 pixels (4B) and not using this function 
(4C). Once binarized, artificacts show up that are unrelated to neurite fragments. 
Additional experimental data that is from the treatments of cells with the drugs  6-OHDA 
and HNE shows that use of the particle remover plugin corresponds to higher D.I.s being 
calculated among nearly every treatment condition, since the meausured total neurite area 
will be decreased. In this data shown in 4D and 4E, the dark bars indicate use of the 
traditional method and the gray bars indicate D.I.s calculated with use of the particle 
remover function. It seems that treatment with HNE causes severe degeneration between 
vehicle and experimental conditions, as shown in 4E. It also appears that treatment with 
6-OHDA has a more dose-dependent effect relating to drug concentration on 
degeneration, as shown in 4D.  
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 Figure 4. Use of the particle remover plugin’s effect on D.I. A; represents an 
original PC image B; binarized PC image with soma removal without the use of the 
particle remover function, seen with a moderate amount of background artifacts across 
the image C; binarized PC image with soma removal with the use of the particle remover 
function, less artifacts show up and a cleaner image is presented D; D.I. data from a 6-
OHDA experiment to assess dose effects on neurite degeneration (n=1). This data shows 
the method that makes use of the particle remover (gray bars) results in higher D.I.s 
quantitatively than when in comparison to the traditional method (black bars) E; D.I. data 
from an HNE experiment to assess dose effects on neurite degeneration (n=1). This 
shows the method that makes use of the particle remover (gray bars) results in higher 
D.I.s quantitatively than when in comparison to the traditional method (black bars). The 
scale bar indicates 100 µm. 
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 D.I. calculations are influenced by particle detection size. In the enhanced method 
another optimization we made narrowed selection criteria for fragmented neurites. These 
fragments are highlighted and detected if they are between a 10-10,000-pixel size. This is 
in comparison to the traditional method that does not include particle removal and only 
measures neurite fragments that are between a 20-10,000-pixel size. In Figure 5 the 
accuracy differences between using a 10-10,000 (5D) and a 20-10,000 (5C) pixel 
detection range is shown. The latter image in 5C presents with more artifact and 
background shading that may affect total neurite area, and there are neurites that are not 
being detected.  
 
Figure 5. Difference between the traditional and enhanced method when it comes to 
pixel particle detection size. A; original PC image of a degenerated culture B; binarized 
PC image with soma removal C; binarized PC image with soma removal that has 
particles of a 20-10,000- pixel size being detected, representative of the traditional 
method D; binarized PC image with soma removal that has particles of a 10-10,000-pixel 
size being detected, representative of the enhanced method. The scale bar indicates 100 
µm. 
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 The traditional method is set up so that during image capture phase-contrast 
microscopy is performed. To qualitatively and quantitatively show that fluorescent 
images provide a more accurate starting image we stained and used fluorescent images to 
obtain D.I. calculations. The following figure shows the qualitative difference between 
using PC and fluorescent images to begin with. The difference becomes apparent once 
binarized. The original PC image binarizes to include background shading and artifacts. 
The original fluorescent binarized image is much clearer with less background noise and 
non-neurite artifacts. The field of view is of a vehicle condition well so the neurons 
should be healthy and not present with artifacts/ fragmentation. This image set also 
includes data from a 6-OHDA experiment to assess dose effects on neurite degeneration 
(n=1). The data indicates that use of fluorescent microscopy enhances the sensitivity with 
which D.I. analyses detect neurite degeneration. D.I. The black bars in panel 6E indicate 
the use of original PC images and the gray bars in panel 6E indicate the use of original 
fluorescent images. The enhanced method presents a more dose dependent effect on 
degeneration when measured using fluorescent images, as shown in 6E.  
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Figure 6. Use of phase-contrast vs fluorescent images. A; PC image that has had 
brightness and contrast enhancements B; binarized PC image that has had brightness and 
contrast enhancements with soma removal C; fluorescent image of staining for the β-III 
tubulin protein D; binarized fluorescent image with soma removal. E; D.I. data from a 6-
OHDA dose response treatment to assess dose effects on neurite degeneration  (n=1) that 
shows the difference in D.I. for the method that uses original PC images (black bars) and 
the method that uses original fluorescent images  (gray bars). The scale bar indicates 100 
µm. 
 As this research developed, a leading motivation for our work began to shift towards 
focusing on creating an automated method for the whole process. The automation of the 
enhanced method makes the whole process more efficient since accurate results may be 
compiled within a fraction of the time of the traditional method. The schematic in Figure 
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7 depicts the automated method and how it works. To automate the method a macro in 
FIJI has been developed. Within this method, a fluorescent image that has had brightness 
and contrast enhancements has been binarized with unwanted particles removed. This 
image serves as “neurite staining” image, as shown in panel 7A. A secondary fluorescent 
image of DAPI nuclear staining is opened. This image has also had brightness and 
contrast enhancements. It has also been binarized with unwanted particles removed, and 
it serves as the “DAPI image”, shown in panel 7B. The outside perimeter of the DAPI 
staining is then expanded ten times using the dilate function and then slightly made 
smaller using the erode function four times. This step is to allow for the nuclear stain to 
emulate a cell body more closely, shown in 7C. The dilated and eroded DAPI image is 
then subtracted from the neurite image to obtain a picture of the neurites without cell 
bodies (7D). Total and fragmented neurite areas are measured and recorded so the D.I.s 
may be calculated. In panels 7E and 7F additional 6-OHDA treatment data is shown from 
PC (n=1) and fluorescent 6-OHDA (n=1) experiments, to assess dose effects on neurite 
degeneration.  For both PC and fluorescent experiments, the automated and the manual 
method show similar D.I. numerical values. The dark bars indicate the manual method, 
and the gray bars indicate the automated method, both shown in 7E and 7F. Both 
experiments show a dose-dependent increase in D.I. values for both of the methods.  
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Figure 7. Automated vs manual methods for quantification of neurite degeneration. 
A; Binarized fluorescent image that has had brightness and contrast enhancements with 
particles removed B; binarized DAPI image that has had brightness and contrast 
enhancements with particles removed C; dilation and erosion processing of DAPI image 
D; represents the resulting image obtained after the dilated and eroded DAPI image has 
been subtracted from the neurite staining image E; Fluorescent D.I. data from 6-OHDA 
experiment to assess dose effects on neurite degeneration  (n=1) that shows the difference 
in D.I. for the manual method (black bars) and the automated method (gray bars) F; PC 
D.I. data from 6-OHDA experiment to assess dose effects on neurite degeneration  (n=1) 
that shows the difference in D.I. for the manual method (black bars) and the automated 
method (gray bars). 
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 Automation of the process greatly increases efficiency. Time estimate data (n=1) for 
both automated and manual methods was performed by using a stopwatch to record the 
time it took to make any necessary modifications and to calculate the D.I. for all the 
image sets within an experiment. Preliminary time data shows that the automated process 
took a shorter amount of time. For the manual method, average processing time for a 
fluorescent image set was 3.1356 minutes/image. In comparison, the average automated 
method only took 0.448 min/image. For a whole dataset with up to 35 images the manual 
method took 1 hour 50 minutes and the automated method took 15.68 minutes to 
complete.  
 
 
 Finally, we sought to demonstrate use of our optimized method in an experiment 
assessing the effects of c-Jun N-terminal Kinase (JNK) on neurite degeneration. To do 
this, we treated LUHMES cells with vehicle, 6-OHDA and SP600125+6-OHDA 
treatment conditions and compared D.I.s. Our results indicated that our optimized method 
allowed us to determine that JNK activation is required for neurite degeneration induced 
by oxidative stress. The data shown in Figure 9 presents the numerical D.I. data for 
Figure 8. Automated vs manual methods 
time estimate data. The dark bar indicates the 
time required to perform the manual method 
on a fluorescent image set, registering with an 
average time of  3.1356 min/image for 
processing time. The time required to perform 
the automated method is indicated by the gray 
bar, registering with an average processing 
time of 0.448 min /image.  
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vehicle, 6-OHDA and SP600125+6-OHDA treatment conditions. The SP600125 was 
used in order to inhibit JNK activation, which lead to a decrease in D.I., corresponding to 
a decrease in degeneration. There is a significant difference between the D.I.s calculated 
for the vehicle and 6-OHDA treatment condition. However, is no significant difference 
between vehicle and SP600125+6-OHDA conditions, which indicates the inhibitor 
properly worked to inhibit JNK activation. 
 
Figure 9. Degeneration data for an 
SP600125 experiment. Veh 
indicates treatment of cell culture 
with control conditions, these cells 
are only treated with what SP600125 
and 6-OHDA are dissolved in, which 
was DMSO and PBS with 0.02% 
ascorbic acid.  6-OHDA indicates 
treatment with the drug 6-OHDA, 
triggering the activation of JNK (a 
protein activated in the stress 
signaling pathway). This was a dose dependent experiment spanning 24-hours, with a 7.5 
µM 6-OHDA treatment condition.  SP6+ 6-OH indicates a one hour pretreatment with 
the JNK inhibitor SP600125 prior to 24-hour treatment with 7.5 µM 6-OHDA (n=4).  
 
42 
 
 These results reveal that the optimized method can accurately be used across all 
treatment conditions.  
Discussion  
 Measuring neurite degeneration is an important avenue of research. Advances in 
this area of research may facilitate development of new therapies. As previously 
discussed, there are issues with existing methods for analyzing neurite degeneration. 
Once we began to research this topic, we applied a method previously described (Sasaki 
et al. 2009) and found several issues with it. In relation to background correction, the 
previously described traditional method to quantify degeneration using D.I. scores did not 
have any information relating to background correction or lighting at the time of image 
capture. This was an apparent issue once we began to apply the technique since once an 
image was binarized, if it did not have appropriate lighting with background correction 
applied, then the image had severe background shading that drastically altered the 
appearance of the image. Total neurite area that was measured was also affected, as seen 
in Figure 2.  Our enhanced method featured use of background correction and optimized 
microscope lighting such that the average grayscale level was at 165, resulting in a 
clearer and seemingly more accurate binarized image.  
Other issues with the traditional method also relate to exposure times and gain 
settings of the microscope. Previously published methods had little information of these 
specifics, yet they still made a difference once an image was binarized. Our team found it 
to be beneficial to capture images at a 20x magnification for all image types. For phase 
contrast images gain was set at 1.00x with a 21 second exposure time. For fluorescent 
images visualizing TUJ-1, gain was set at 1.20x with an exposure that ranged from 900 
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ms to 2 seconds. DAPI images were captured with a 2.80x gain and a 125 ms exposure 
time for best results. These settings are specifically for a Nikon inverted microscope.   
 The act of performing brightness and contrast enhancements is also an important 
step to take to get an accurate neurite fragment area measurement. If this step is not 
properly performed there may be artificial fragmentation that occurs, as depicted in 
Figure 3. The same reasoning applies for use of the particle remover plugin within FIJI. 
Use of this function affects the total neurite area that is recorded, as shown in Figure 4. In 
the enhanced method the smallest neurite fragments that are measured are 10.0 pixels, 
and so it is necessary to remove anything smaller than that to get an accurate 
measurement. Another way the enhanced method has improved upon the traditional 
method is also seen qualitatively in difference in particle detection size, shown in Figure 
5. Detection of particles between 20-10,000-pixels does not identify all the fragments that 
show up within the image, and so it is also necessary to drop the threshold of detection to 
measure between 10-10,000-pixel particles.  
 When examining Figure 6, there is more qualitive data that supports the use of 
original fluorescent images for the enhanced method. Once binarized the fluorescent 
images present with much less background noise when compared to phase contrast 
images. These findings are further supported by data from another group who also used 
β-III tubulin and fluorescent images to quantify neurite degeneration. In their studies cells 
were exposed to m-Dinitrobenzene (m-DNB), a selected model neurotoxicant, and then 
immunostained and visualized with fluorescent microscopy. They also increased contrast 
by using the Enhance Local Contrast (CLAHE) plugin within FIJI to outline cell 
morphology more precisely. Their images were then binarized in order to threshold to 
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create a contour of the area of the cell and the count particles plugin was used to identify 
neurite fragmentation. Based on visual observations of several images of neurites, 
particles below 2.5 μm were considered to be either debris or background artifacts. Then 
they compared time trial data to see the effect the m-DNB had on neurite degeneration. 
As expected, the neurites exposed to higher concentrations of m-DNB for longer periods 
of time had higher amounts of degeneration (Dixon and Philbert 2016).  
Another study relating to microtubules gives support for using β-III tubulin to 
showcase neurite degeneration. Reduction in neurite length, number of neurite branches 
and synaptic terminals, seen in PD patients, has been linked to increased microtubule 
depolymerization in the absence of functional Parkin. This is an important enzyme 
involved in ubiquitination- the process whereby molecules are covalently labelled 
with ubiquitin (Ub) and get labeled for destruction via proteasomes or lysosomes (Dubey 
et al. 2015). This supports the idea that β-III tubulin may have the same pattern of 
degradation as neurites. 
 The enhanced method that we have created also alleviates the issue of subjectivity 
that prior methods have. For example, the research team previously discussed, led by 
Engelmann, counted axons by use of a blinded examiner, however depending on the 
examiner, the results may have been subjective (Engelmann et al. 2020). In the manual 
method of obtaining a D.I., there is the step of using the eraser tool within FIJI to erase 
cell bodies and artifacts unrelated to neurites. This step may lead to inaccuracies due to 
subjectivity of what an investigator deems to be a cell body or not. Sometimes it may be 
difficult to tell if a neurite is connected to a cell body or a blebbed section, so depending 
on the individual doing the manual cell body subtraction, there may be differing D.I. 
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values produced for the same image. Subjectivity may also be introduced depending on 
what tool is used for the cell body subtraction. The free hand selection or the eraser tool 
may be used to eliminate the soma, however depending on which one is used, there also 
may be varying results. Other methods of quantifying neurite degeneration that may be 
associated with subjectivity include visually scoring neurite fragmentation on a scale of 
0-1.0. This is much like giving a sample a D.I. score but instead of using mathematical 
measurement of areas, the investigator views the image and gives it a representative 
score. An advantage of our enhanced method is that it automates the cell body subtraction 
process and uses DAPI staining to identify nuclei uniformly and therefore cell bodies 
more objectively. It also leaves no room for user error or subjectivity since it is 
automated, containing programmed steps and use of a formula to create a score to 
represent fragmentation.   
Another issue that relates to the manual method involves timing and efficiency. 
Cell body subtraction is subjective, but it is also very time consuming. On average for a 
fluorescent image set the manual method took 3.1356 min/image. This corresponded to a 
1 hour and 50-minute complete processing time to obtain D.I. calculations for a whole 
data set. This is in comparison to the automated method that only took on average 0.448 
min/image. This corresponded to a 15.68 min complete processing time for a whole data 
set, that included 35 images. The use of the macro within FIJI saves time and increases 
efficiency, since data sets can have up to 120 images and use of the macro allows 
simultaneous application of many modifications to whole image sets. Even before 
developing the automated method there were modifications made to try to save time 
when performing cell body subtraction. Investigators first began the process using a 
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computer mouse pad to select and circle areas deemed to be a cell body so that they could 
be deleted from the image. Use of a computer mouse helped to slightly quicken the 
process due to easier and more fluid wrist movements. However, it still was a lengthy 
process. Another adjustment made was using a touch screen tablet and a stylus along with 
the eraser tool to easily touch and delete cell body selections. Though this action made a 
pronounced difference in the time it took to remove cell bodies, it still took a drastically 
longer time than it took making use of the automated method. 
In addition to being efficient the enhanced automated method is more user-
friendly. The traditional method presented with issues that needed to be fixed in order to 
obtain accurate D.I. data. To correct these issues, adjustments were made using 
brightness and contrast settings, along with use of the particle remover function. Our 
method makes use of a macro which reduces the number of steps needed when compared 
to the traditional method. Our method also provides novice learners the information they 
need so they do not have to be experienced with FIJI in order to obtain accurate D.I. data, 
further simplifying the method.  
Other groups in the past have used differences in overall neurite length as a way 
to quantify degeneration. For example, a research team compared neurons transfected 
with a control protein with neurons that had overexpression of the wildtype versions of α-
synuclein. Their results indicated that neurite length significantly was reduced in the cells 
that contained α-synuclein (Furlong et al. 2020). This result is to be expected since one 
would assume if degeneration is occurring that there would be some type of 
fragmentation or shortening of the neurite. The problem with measuring neurite length to 
indicate degeneration presents itself when there is differing data that is published, which 
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seemingly makes the method itself seem unreliable. For example, another group that 
treated rat hippocampal neurons with 6-OHDA and SP600125 saw shortening of neurites 
of neurons that were treated with the SP600125 and elongation of cells that had JNK 
activation present (Eminel et al. 2008). JNK is a specific type of protein that plays a dual 
role in death signaling pathways and neurite outgrowth. This research team’s effort is a 
good example of why measuring neurite outgrowth alone is not a reliable way to measure 
degeneration. Our SP600125+6-OHDA experiment to assess JNK’s role on neurite 
degeneration data indicated higher degrees of fragmentation for cells that had been 
exposed to oxidative stress and lower D.I.s for the SP600125 pretreatment conditions. 
Our method seems to present more consistent results that align with other research that 
has reported on the damage that 6-OHDA may induce. The data presented in Figure 9 
also validates use of the automated method within the context of an actual experiment. 
The D.I. values between the 6-OHDA and vehicle conditions were significantly different. 
The method that uses loss of neurite length to indicate degeneration may have issues due 
to the blebbing of neurites. A neurite may become blebbed but not have a significant 
change in overall length, or the neurite may become fragmented without a substantial 
change in length. Our method makes use of measuring neurite fragments so that it may be 
compared to total neurite area, so that issue does not apply with the enhanced method.  
In conclusion, the method that we present is more accurate, efficient, and user-
friendly than the traditional method of quantifying neurite degeneration making use of a 
degeneration index. Through modifications of the process relating to image capture and 
processing in FIJI, we have been able to develop an accurate, automated method. A 
future study that could help to further validate use of this new method could be to 
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compare the fluorescent  β-III tubulin signal with whole cellular structure to further 
support the notion that β-III tubulin follows the same pattern of degradation as the 
neurites. Hopefully, this enhanced and automated method may be used to evaluate novel 
therapies relating to Parkinson’s disease in the future.  
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